Argos Therapeutics (ARGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGS | AZN | AMGN | GILD | BMY |
| Company | Argos Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.1000 | 190.33 | 368.27 | 143.50 | 59.92 |
| High | 0.1100 | 192.88 | 373.13 | 145.59 | 60.52 |
| Low | 0.0950 | 189.35 | 366.53 | 143.49 | 59.25 |
| Latest | 0.1000 | 192.77 | 372.60 | 144.65 | 59.84 |
| Change | unch | -1.45 | +3.07 | +0.72 | -0.45 |
| % Change | unch | -0.75% | +0.83% | +0.50% | -0.75% |
| Volume | 67,400 | 648,749 | 448,728 | 892,354 | 2,232,090 |
| 20-Day Average Volume | 41,480 | 2,211,663 | 2,570,030 | 7,246,504 | 12,510,890 |
| Previous Close | 0.1000 | 194.22 | 369.53 | 143.93 | 60.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1250 | 202.33 | 375.30 | 149.43 | 60.85 |
| 20-Day Raw Stochastic | 37.50% | 15.20% | 20.02% | 9.85% | 1.91% |
| 20-Day Relative Strength | 42.27 | 45.23 | 52.35 | 51.94 | 52.20 |
| Weighted Alpha | -89.28 | +27.40 | +24.30 | +35.28 | +12.10 |
| Today's Opinion | N/A | 64% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | N/A | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.09% since 11/27/18 | -6.27% since 03/02/26 | -4.83% since 03/02/26 | -3.89% since 03/02/26 | -4.88% since 03/02/26 |
| Low | 0.0700 on 11/30/18 | 189.43 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 0.1380 on 11/29/18 | 203.29 on 03/04/26 | 381.74 on 03/03/26 | 148.92 on 03/04/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | -30.31% since 11/02/18 | +1.57% since 02/09/26 | -2.33% since 02/09/26 | -4.93% since 02/09/26 | -2.42% since 02/09/26 |
| Low | 0.0700 on 11/30/18 | 189.43 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 0.1500 on 11/12/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -16.67% since 09/04/18 | +6.30% since 12/09/25 | +16.96% since 12/09/25 | +20.81% since 12/09/25 | +17.08% since 12/09/25 |
| Low | 0.0700 on 11/30/18 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 0.2500 on 10/15/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -37.58% since 06/04/18 | +17.56% since 09/09/25 | +31.11% since 09/09/25 | +24.57% since 09/09/25 | +25.56% since 09/09/25 |
| Low | 0.0700 on 11/30/18 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.2500 on 10/15/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,059 | 301,217,344 | 199,201,792 | 178,677,728 | 122,779,024 |
| Shares Outstanding, K | 10,590 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 1,900,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -40,580,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,250,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -5,000,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.48 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 12/06/18 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.56 | 16.82 | 17.81 | 9.88 |